ResearcherLund UniversityActive in the last 2 years
Sofie Olsson Hau
Matched on ORCID iD 0000-0002-1702-9884; OpenAlex author ID A5048918010. Sources: ClinicalTrials.gov.
Their work
- Papers
- 4
- Trials
- 1
- Grants
- 0
- Labs led
- 0
- Collaborators
- 8
2018: 1 trial · 2019: none · 2020: none · 2021: none · 2022: 2 papers · 2023: none · 2024: none · 2025: 1 paper · 2026: 1 paper
Papers 4
- Systemic and local decorin levels mirror the clinical course of pancreatic cancer. Co-author DOI 10.1002/2056-4538.70066↗
- Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in patients with newly diagnosed pancreatic c… Co-author DOI 10.1038/s41598-025-22369-5↗
- PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer. Co-author DOI 10.1002/cjp2.238↗
- Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Cancer. Co-author DOI 10.1158/1541-7786.mcr-21-0986↗
Trials 1
Closest collaborators
The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Karin Jirström · 4 shared papers, 1 shared trial, 2018–2026 · strength 1.03
- Paper Systemic and local decorin levels mirror the clinical course of pancreatic cancer. DOI 10.1002/2056-4538.70066↗
- Paper Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in pa… DOI 10.1038/s41598-025-22369-5↗
- Trial Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer NCT03724994↗
- Maja Svensson · 2 shared papers, 2025–2026 · strength 0.56
- Karin Leandersson · 2 shared papers, 1 shared trial, 2018–2025 · strength 0.55
- Paper Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in pa… DOI 10.1038/s41598-025-22369-5↗
- Trial Chemotherapy, Host Response and Molecular Dynamics in Periampullary Cancer NCT03724994↗
- Paper Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Can… DOI 10.1158/1541-7786.mcr-21-0986↗
- Jakob Eberhard · 3 shared papers, 2022–2025 · strength 0.52
- Paper Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in pa… DOI 10.1038/s41598-025-22369-5↗
- Paper PRR11 unveiled as a top candidate biomarker within the RBM3-regulated transcriptome in pancreatic cancer. DOI 10.1002/cjp2.238↗
- Paper Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Can… DOI 10.1158/1541-7786.mcr-21-0986↗
- Alexandra Petersson · 2 shared papers, 2022–2025 · strength 0.37
- Paper Reliable on-treatment prognostication and target identification with a customized assay for circulating tumor DNA in pa… DOI 10.1038/s41598-025-22369-5↗
- Paper Branching Copy-Number Evolution and Parallel Immune Profiles across the Regional Tumor Space of Resected Pancreatic Can… DOI 10.1158/1541-7786.mcr-21-0986↗
- Jacob Elebro · 2 shared papers, 2022 · strength 0.29
- Margareta Heby · 1 shared trial, 2018 · strength 0.18
- Emelie Karnevi · 1 shared paper, 2022 · strength 0.15
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.